While this assay was not analytically validated here for the determination of copy number variation, outlier coverage suggested amplification of EGFR in HCC827, which has been previously reported [11], and deletion of PTEN in “Biopsy 2” used for frozen tumor mixes (not confirmed). This evidence concerns the gene EGFR and neoplasm.